Myriad myPlan Lung Cancer Test Provided to Leading Physicians
Test accurately identifies which patients may need postsurgical chemotherapy.
Read MorePosted by Judy O'Rourke | Oct 29, 2013 | Cancer, Lung Cancer, Molecular Diagnostics |
Test accurately identifies which patients may need postsurgical chemotherapy.
Read MorePosted by Judy O'Rourke | Sep 18, 2013 | Cancer, Lung Cancer, Molecular Diagnostics, Research |
Findings could help identify patients most likely to benefit from lung-sparing surgery.
Read MorePosted by Judy O'Rourke | Sep 18, 2013 | Cancer, Lung Cancer, Molecular Diagnostics |
The test uses a panel of tumor antigens to diagnose autoantibodies produced by the patient’s immune system when lung cancer is present.
Read MorePosted by Clinical Lab Products | Aug 26, 2013 | Cancer, Molecular Diagnostics |
The new, nearly $1.5 million contract with further the development of a panel of assays designed to provide a fast and accurate way to identify and characterize biomarkers estimated to constitute up to 9% of NSCLC cases.
Read MorePosted by Clinical Lab Products | Aug 15, 2013 | Cancer, Heart Disease, Miscellaneous |
Mid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read More